Home • SuperSonic Imagine • Founders



Jacques Souquet

Ph.D. founder and Executive Vice President, Chief Strategic and Innovation Officer of SuperSonic Imagine, held the position of CEO of SuperSonic Imagine from its creation in 2005 to April 2015.

From 2000 to 2005 Dr. Souquet served as Chief Scientific and Technology Officer (CTO) and Senior Vice President of Philips Medical Systems.

From 1993 to 2000 he was CTO and Senior Vice President for Product Generation at ATL Ultrasound.

From 1989 to 1993, Jacques served as Director of Strategic Marketing and Product Planning and Vice President for Product Generation of ATL Ultrasound. He joined ATL Ultrasound in August 1981 as a principal scientist in the cardiology division.

Dr. Souquet holds a Higher Engineering Degree from the Ecole Superieure d'Electricite of Paris, France, a Ph.D. in the field of optical memory, from Orsay University , France , and a Ph.D. in the field of new acoustic imaging techniques for medical ultrasound applications and nondestructive testing from Stanford University.

He is the inventor of the multiplane transesophageal echo probe, which is now used in 30% of all ultrasound echocardiography examinations.

Dr. Souquet is the owner of 10 patents in the field of ultrasound imaging.

He is also the author of more than 50 technical papers and is a keynote speaker at major technical and clinical meetings worldwide.



Armen Sarvazyan

Armen Sarvazyan, PhD, DSc.: Chief Scientist and Founder of Artann Laboratories, Trenton, NJ, Adjunct Professor at the Robert Wood Johnson Medical School and Honorary Foreign Professor of Physics Faculty of Moscow State University, Russia.

Holding over 100 international patents on ultrasonic and biomechanical methods and devices, Armen Sarvazyan has edited 6 books and published over 200 research papers.

Patented inventions of Sarvazyan include a variety of novel diagnostic modalities:

  • mechanical imaging - a novel, non-invasive method of medical diagnosis specifically for detection of breast and prostate cancer
  • ultrasonic and MRI shear wave elasticity imaging
  • ultrasound sonography for detection of osteoporosis and  assessment of bone fracture risk.

Since the last decade, Sarvazyan received over 30 research grants and contract awards from various agencies, including the National Institute of Health, NASA and the US Department of Defense.



Claude Cohen-Bacrie

Co-founder and Scientific Director of SuperSonic Imagine

Prior to working at SuperSonicImagine, Claude Cohen-Bacrie held the position of cluster leader for ultrasound activity, Philips Research USA. This post involved the development of ultrasound research in core ultrasound beamforming technology and new business development for ultrasound.

From 1996 to 2002, he was senior scientist at Philips Research France. His research interests included ultrasound vascular applications and elastography for the breast. He led a multinational research project on breast ultrasound from 1999 to 2002 and launched several clinical investigations for new imaging protocols at various sites in France and  the United States.

Claude received an electrical engineering and computer science degree  from the Ecole Nationale Supérieure de l'Electronique et de ses Applications in 1992.

He graduated in 1992 from the Orsay University, Paris with a Masters degree in signal and image processing. He then specialized in medical imaging and biomedical engineering at  the Ecole Polytechnique de Montreal, Canada, and worked on Electrical Impedance Tomography with an application for lung emphysema detection.

He then graduated with a second Masters degree in 1994 and started  as a research assistant with Electricite de France to develop innovative algorithms on Eddy current tomography for non destructive testing.

Claude Cohen-Bacrie is the recipient of 10 patents in the field of medical imaging and makes regular contributions to key scientific conferences in the field of ultrasound.



Damien Dolimier

Co-founder and software director of SuperSonic Imagine

Damien Dolimier was the instigator of the QLAB ultrasound quantification platform which offers clinicians and researchers valuable novel diagnostic tools for both on-line and off-line use.

He is also  the creator of the HDILab software, a very powerful software program used by more than 200 researchers worldwide.

Damien has a degree in engineering, signal & image processing from l'Ecole Polytechnique de l'Université d'Orléans, France.

He has more than 15 years of experience designing and developing professional applications.



Georges Charpak (1924-2010)

A french physicist, Geoges Charpak was awarded the 1992 Nobel Prize for Physics. He was a member of the French Academy of Sciences and founder of BioSpace.

Georges Charpak was born in 1924 in Dabrovica, Poland, and became a French citizen in 1946.

He studied in Montpellier and Paris. In 1946 he received his BSc in Engineering. He holds a PhD in Physics (including experimental research in nuclear physics) from the Collège de France.

Georges worked at the CNRS from 1948 to 1959, before moving to CERN in Geneva. In 1984 he was awarded the Joliot-Curie Professor at the Ecole Supérieure de Physique et de Chimie of Paris.

In 1992 Georges Charpak was awarded the Nobel Prize for Physics for the development of particle detectors, specializing in the multiwire proportional chamber, an elegant and economical solution to a complex problem.

His pioneering work came in 1968, when he realized the importance of connecting the detector directly to a computer, enabling researchers to record the trajectories of particles with great accuracy and in much larger numbers compared with previous techniques.

He created many new types of detectors that have played a fundamental role in the subnuclear physics of the past twenty years and in the development of new imaging techniques using ionizing and beta radiation recently adopted in medicine and biology.

Georges Charpak received many international awards and honors, including the Paul Ricard Prize of the Societé Française de Physique in 1980, the Prize from the Commissariat à l'Energie Atomique de l'Académie des Sciences in 1984 and the High Energy and Particle Physics Prize awarded by the European Physical Society in 1989.

He was a member of the Académie Française des Sciences and an honory member of the National Academy of Sciences in the United States, the Russian Academy of Sciences and the Austrian Academy of Sciences.



Mathias Fink

Mathias Fink is Director of the Laboratoire Ondes et Acoustique of ESPCI, Paris, a member of the French Academy of Sciences and of the French Academy of Engineering and is renowned worldwide for his ultrasound expertise.

Mathias Fink is a Professor of Physics at the Ecole Supérieure de Physique et de Chimie Industrielles in Paris (ESPCI) and Paris 7 University (Denis Diderot), France.

In 1990 he founded the waves and acoustic laboratory at ESPCI. In 2002, he was elected to the French Academy of Engineering and in 2003 to the French Academy of Science.

Mathias Fink’s main area of research is concerned with the propagation of waves in complex media and the development of numerous instruments based on this research.

The application fields for this research is vast: medical imaging and therapy, underwater acoustics, seismology, non-destructive testing, telecommunications, tactile screens and instrumentation. He has a long history of collaboration with industry.

He works with companies in a wide variety of sectors (medical, aeronautics, underwater acoustics, nuclear, metallurgy, instrumentation).

Mathias Fink pioneered many innovative approaches such as “time-reversal mirrors” and “transient elastography”. He holds more than 30 patents and he has published more than 300 papers.



Mickaël Tanter

Mickaël Tanter, Ph.D., is Research Director of the French Institute for Health and Medical Research (I.N.S.E.R.M.). He is an expert in medical imaging and ultrasonic therapy.

Mickaël currently heads the team of “Wave Physics for Medicine” at the Laboratoire Ondes et Acoustique, ESPCI, in Paris, France. 

He received a Diplôme d’Ingénieur Sup'Elec (Higher Engineering Degree) from Ecole Supérieure d’Electricité, Paris in 1994 and a Diplôme d’Etudes Approfondies (M.Sc. degree) from Paris VII University in Physics and Acoustics. In 1999 he was awarded a Ph.D. in Applied Physics from the Paris VII University. 
Between 2000 and 2005, Mickael was a research associate professor of CNRS at the Laboratoire Ondes et Acoustique at E.S.P.C.I. in Paris and  in 2006 joined the French Institute for Medical Research (INSERM) as a research director.His main activities involve the development of new medical imaging and therapy techniques. His current research interests covers a wide range of topics: transcranial ultrasonic therapy and echographic imaging of the brain, elasticity imaging of organs using ultrafast scanners, ultrafast imaging,... 

Mickaël is often invited to speak at international scientific meetings in the field of ultrasound. He is the author of more than 60 peer reviewed scientific papers and the recipient of 15 patents in the field of wave physics.



Jérémy Bercoff

Co-founder and Chief Scientific & Technology Officer at SuperSonic Imagine. He is one of the inventors of ShearWave Elastography, key technology of the company.

Jeremy Bercoff graduated in 2001 from the Ecole Supérieure de Physique et de Chimie de Paris (ESPCI) with a specialization in physics. He worked as an R&D engineer at Philips Medical System (in 1999 and again from 2001 to 2004) and received in 2004 a Ph.D in Physics at the University of Paris VII for his work on ultrafast imaging and shear wave propagation.

Co-founder of  SuperSonic Imagine in 2005 to achieve the technological transfer of his PhD work in a new product and lead the development and implementation of the ShearWave™ Elastography mode. Today, he manages product definition and ultrasound technology developments for the company. He published over 35 scientific papers and is the owner of 8 patents in the medical imagery field.

Be always one step ahead!
Subscribe to our newsletter and be informed first on new products or events.